Cortisone in Ulcerative Colitis

1954/08/14 by S. C. Truelove, L. J. Witts · 541 citations
Medicine · #Colitis #Cortisone #Dermatology #Disease #Gastroenterology #Internal medicine #Medicine #Microscopic Colitis #Ulcerative colitis

paper · pdf · doi:10.1136/bmj.2.4884.375

published in BMJ 2(4884), 375-378

openalex publication_date 1954/08/14 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Cortisone in Ulcerative Colitis
• Mucosal Healing in Ulcerative Colitis: A Comprehensive Review
• Traditional corticosteroids for induction of remission in Crohn's disease. [europepmc]
• Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis. [europepmc]
• High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India. [europepmc]
• Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis. [europepmc]
• Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis. [europepmc]
• Pediatric inflammatory bowel disease: Is it really uncommon in Asian children? [europepmc]
• Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort. [europepmc]
• Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis. [europepmc]
• Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management. [europepmc]
• Predicting Therapeutic Response in Pediatric Ulcerative Colitis-A Journey Towards Precision Medicine. [europepmc]
• Serum complement C3 and α 2 -macroglobulin are potentially useful biomarkers for inflammatory bowel disease patients. [europepmc]
• WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting. [europepmc]
• The Gut-Brain Axis in Inflammatory Bowel Disease-Current and Future Perspectives. [europepmc]
• Neutrophils prevent rectal bleeding in ulcerative colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis. [europepmc]
• Sigmoidoscopic extent of ulcerative colitis and associated factors in Pakistani population. [europepmc]
• Factors Predictive of Proximal Disease Extension and Clinical Course of Patients Initially Diagnosed with Ulcerative Proctitis in an IBD Referral Center. [europepmc]
• Clinical results following colonic resection for ulcerative colitis in elderly individuals (elderly-onset vs. nonelderly onset). [europepmc]
• Stem Cell-Based Therapies for Inflammatory Bowel Disease. [europepmc]
• A review of the therapeutic management of ulcerative colitis. [europepmc]
• A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis. [europepmc]
• Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX versus 5-aminosalicylates or placebo in ulcerative colitis: a systematic review and meta-analysis. [europepmc]
• Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study. [europepmc]
• Interrelation of Hypoxia-Inducible Factor-1 Alpha (HIF-1 α) and the Ratio between the Mean Corpuscular Volume/Lymphocytes (MCVL) and the Cumulative Inflammatory Index (IIC) in Ulcerative Colitis. [europepmc]
• Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium. [europepmc]
• Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis. [europepmc]